Vor Biopharma Inc.
VOR
$17.27
-$0.81-4.48%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -15.01% | 234.08% | -34.69% | 46.36% | -26.91% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -50.20% | -66.78% | 7.47% | -0.02% | 3.86% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -55.38% | 863.64% | -21.84% | 33.33% | 4.78% |
| Total Current Assets | -15.83% | 216.02% | -32.81% | 43.41% | -25.44% |
|
|
|||||
| Total Current Assets | -15.83% | 216.02% | -32.81% | 43.41% | -25.44% |
| Net Property, Plant & Equipment | 13,708.33% | -99.94% | -4.58% | -4.99% | -4.55% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.05% | -91.22% | -0.29% | -2.62% | -10.06% |
| Total Assets | -14.19% | 87.88% | -23.50% | 23.19% | -18.08% |
|
|
|||||
| Total Accounts Payable | 32.29% | -82.07% | 147.97% | 14.36% | -34.43% |
| Total Accrued Expenses | -69.53% | 569.02% | -32.63% | 45.41% | 15.43% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 1.21% | 1.25% | 1.22% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -67.95% | 251.37% | -10.13% | 29.75% | 3.94% |
|
|
|||||
| Total Current Liabilities | -67.95% | 251.37% | -10.13% | 29.75% | 3.94% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -3.98% | -3.75% | -3.42% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 44.05% | -- | -- | -- | -- |
| Total Liabilities | 40.36% | 3,856.87% | -6.46% | 7.41% | -1.08% |
|
|
|||||
| Common Stock & APIC | 16.67% | 0.34% | 0.34% | 10.91% | 0.46% |
| Retained Earnings | -39.39% | -321.50% | -7.11% | -7.20% | -6.91% |
| Treasury Stock & Other | -14.29% | -39.13% | 4.55% | -67.65% | 197.14% |
| Total Common Equity | -47.80% | -2,378.98% | -31.65% | 32.50% | -25.62% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -47.80% | -2,378.98% | -31.65% | 32.50% | -25.62% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -47.80% | -2,378.98% | -31.65% | 32.50% | -25.62% |
|
|
|||||